These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10702797)

  • 21. Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice.
    Zhang M; Shi Y; Magit D; Furth PA; Sager R
    Oncogene; 2000 Dec; 19(52):6053-8. PubMed ID: 11146557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.
    Jerry DJ; Kittrell FS; Kuperwasser C; Laucirica R; Dickinson ES; Bonilla PJ; Butel JS; Medina D
    Oncogene; 2000 Feb; 19(8):1052-8. PubMed ID: 10713689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammary tumor formation in p53- and BRCA1-deficient mice.
    Cressman VL; Backlund DC; Hicks EM; Gowen LC; Godfrey V; Koller BH
    Cell Growth Differ; 1999 Jan; 10(1):1-10. PubMed ID: 9950212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutant p53 promotes epithelial-mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP-T mice.
    Lenfert E; Maenz C; Heinlein C; Jannasch K; Schumacher U; Pantel K; Tolstonog GV; Deppert W; Wegwitz F
    Int J Cancer; 2015 Mar; 136(6):E521-33. PubMed ID: 25195563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammary carcinogenesis in transgenic mice expressing a dominant-negative mutant of DNA polymerase beta in their mammary glands.
    Wang L; Bhattacharyya N; Rabi T; Wang L; Banerjee S
    Carcinogenesis; 2007 Jun; 28(6):1356-63. PubMed ID: 17166880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
    BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
    Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
    Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bax accelerates tumorigenesis in p53-deficient mice.
    Knudson CM; Johnson GM; Lin Y; Korsmeyer SJ
    Cancer Res; 2001 Jan; 61(2):659-65. PubMed ID: 11212265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice.
    Kirma N; Gill K; Mandava U; Tekmal RR
    Cancer Res; 2001 Mar; 61(5):1910-8. PubMed ID: 11280746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
    Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
    Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.
    Sandgren EP; Schroeder JA; Qui TH; Palmiter RD; Brinster RL; Lee DC
    Cancer Res; 1995 Sep; 55(17):3915-27. PubMed ID: 7641211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of cell apoptosis by insulin-like growth factor I.
    Hadsell DL; Abdel-Fattah G
    Adv Exp Med Biol; 2001; 501():79-85. PubMed ID: 11787734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic mouse with human mutant p53 expression in the prostate epithelium.
    Elgavish A; Wood PA; Pinkert CA; Eltoum IE; Cartee T; Wilbanks J; Mentor-Marcel R; Tian L; Scroggins SE
    Prostate; 2004 Sep; 61(1):26-34. PubMed ID: 15287091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in Apc and p53 synergize to promote mammary neoplasia.
    Méniel V; Hay T; Douglas-Jones A; Sansom OJ; Clarke AR
    Cancer Res; 2005 Jan; 65(2):410-6. PubMed ID: 15695381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.
    De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M
    Cancer Res; 2003 Feb; 63(4):793-800. PubMed ID: 12591728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
    Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
    Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is conversion of solid into more anoxic ascites tumors associated with p53 inactivation?
    Magnusson KP; Satalino R; Qian W; Klein G; Wiman KG
    Oncogene; 1998 Nov; 17(18):2333-7. PubMed ID: 9811464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.
    Torres-Arzayus MI; Font de Mora J; Yuan J; Vazquez F; Bronson R; Rue M; Sellers WR; Brown M
    Cancer Cell; 2004 Sep; 6(3):263-74. PubMed ID: 15380517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.